Gonapeptyl

Gonapeptyl is a prescription medication that contains the active ingredient triptorelin acetate, a synthetic GnRH agonist, supplied as a subcutaneous injection. It is marketed in the European Union and is used in hormone therapy to modulate the pituitary‑gonadal axis. The drug works by initially stimulating then down‑regulating GnRH receptors, leading to reduced LH and FSH secretion and suppression of sex hormone production in patients requiring hormonal control.

Gonapeptyl is indicated for several hormone‑dependent conditions where suppression of gonadotropins is desired.

- Treatment of advanced or metastatic prostate cancer in combination with androgen deprivation therapy. - Management of endometriosis to reduce pelvic pain and lesion growth. - Therapy for symptomatic uterine fibroids to control bleeding and shrink fibroid size. - Treatment of central precocious puberty to delay early sexual development. - Use as part of assisted reproduction protocols to control ovarian stimulation timing.

Like other GnRH agonists, Gonapeptyl can cause a range of adverse effects that vary in frequency and severity.

Common: - Hot flashes or sweating. - Headache. - Injection site pain or redness. - Fatigue.

Serious: - Severe allergic reaction (anaphylaxis) with rash, swelling, or breathing difficulty. - Cardiovascular events such as hypertension or arrhythmia. - Bone mineral density loss leading to osteoporosis.

Before prescribing Gonapeptyl, clinicians should evaluate several precautionary factors to ensure safe use.

- Assess cardiovascular risk, especially in patients with hypertension or heart disease. - Evaluate bone health; prolonged therapy may increase risk of osteoporosis. - Monitor liver function tests during treatment. - Use caution in patients with a history of allergic reactions to peptide drugs. - Consider potential impact on glucose metabolism in diabetic patients. - Review reproductive status; pregnancy is contraindicated and contraception is required.

Gonapeptyl may interact with other medicines, altering its effectiveness or increasing adverse effects.

Avoid: - Concurrent use with other GnRH agonists or antagonists, which can lead to excessive hormone suppression. - Strong CYP3A4 inducers that may reduce triptorelin plasma levels (e.g., rifampin).

Use with caution: - Hormonal contraceptives, as Gonapeptyl can diminish their efficacy. - Anticoagulants, because injection site bleeding may be prolonged. - Antidiabetic agents, since hormonal changes can affect blood glucose control.